Volume: 57 - Issue: 1
First page: 57 - Last page: 66
Chien-Chia Huang - Ta-Jen Lee - Chi-Che Huang - Po-Hung Chang - Chia-Hsiang Fu - Pei-Wen Wu - Chun-Hua Wang
Background: Cigarette smoke have adverse effects in the control of asthma and chronic rhinosinusitis (CRS). Interleukin (IL)-17A,
the signature cytokine of helper T 17 cells and group 3 innate lymphoid cells (ILC3), has been reported to link with resistance to
therapy in airway inflammation. This study aimed to investigate the impact of cigarette smoking and IL-17A activation on the clinical outcomes of asthmatic patients with chronic rhinosinusitis.
Methods: 33 patients with CRS and asthma, including 15 smokers and 18 non-smokers, and 7 asthmatic patients without CRS and
smoking were prospectively recruited. The Sino-Nasal Outcome Test-22 and Asthma Control Test were used to evaluate sinonasal
symptoms and the level of asthma control, respectively. Real-time PCR and immunostaining were applied to evaluate the expression levels of IL-17A and associated immunological factors on surgically-obtained nasal tissues.
Results: Nasal surgery improved both sinonasal symptoms and asthma control. Compared to non-smokers, smokers showed
poorer improvement in asthma control. The expression of IL-17A, IL-22, aryl hydrocarbon receptor (AhR), and ILC3 was increased in
the nasal tissues of smokers with asthma and CRS. The expression of IL-17A mRNA was correlated with that of AhR and with positive nuclear AhR-AhR nuclear translocator staining cells, and that of cyclooxygenase-2 enzyme (COX-2). ILC3 cells were associated
with IL-17A, IL-22, AhR, and COX-2 mRNA expression.
Conclusions: Cigarette smoking was related to lesser improvement in asthma control after nasal surgery and to IL-17A activation
in the nasal tissues of patients with inflammatory airways.
Rhinology 57-1: 57-66, 2019
To see the issue content and the abstract you do not have to login
Please login to download the full articles
If you do not have a subscription to Rhinology please consider taking one.